Skip to main content
. 2022 May 27;14(11):2661. doi: 10.3390/cancers14112661

Figure 1.

Figure 1

Computed tomography scan showing the initial radiological aspect of tumor and lymph nodes (A,C) compared to the aspect after treatment with pembrolizumab (B,D).